28359890|t|Artemisinin loaded chitosan magnetic nanoparticles for the efficient targeting to the breast cancer
28359890|a|Artemisinin, a natural anti-malarial agent, also possesses anti-proliferative and anti-angiogenic activity in cancer cells with very low toxicity to normal healthy cells. Drug loaded magnetic nanoparticles by using external magnetic field could selectively accumulate the drug at the target site and thereby reduce the doses required to achieve therapeutic concentration which may otherwise produce serious side effects on healthy cells. In the present study the artemisinin magnetic nanoparticles were successfully formulated using chitosan by ionic-gelation method. The developed magnetic nanoparticles of artemisinin were smooth and spherical in nature and their size was in the range of 349-445nm. The polydispersity index (PDI) and zeta potential of the formulated nanoparticles were in the range of 0.373-0.908 and -9.34 to -33.3 respectively. They showed 55% to 62.5% of drug encapsulation efficiency and 20% to 25% drug loading capacity. Around 62% to 78% of artemisinin was released from the artemisinin magnetic nanoparticles over the period of 48h. On application of physiologically acceptable external magnetic field, FITC conjugated artemisinin magnetic nanoparticles showed an enhanced accumulation of nanoparticles in the 4T1 breast tumour tissues of BALB/c mice model.
28359890	0	11	Artemisinin	T109,T121	C0052430
28359890	19	27	chitosan	T109,T121	C0162969
28359890	28	50	magnetic nanoparticles	T073	C1450054
28359890	69	78	targeting	T169	C0205245
28359890	86	99	breast cancer	T191	C0006142
28359890	100	111	Artemisinin	T109,T121	C0052430
28359890	123	142	anti-malarial agent	T121	C0003374
28359890	159	177	anti-proliferative	T033	C0243095
28359890	182	206	anti-angiogenic activity	T033	C0243095
28359890	210	222	cancer cells	T025	C0334227
28359890	237	245	toxicity	T037	C0600688
28359890	249	255	normal	T080	C0205307
28359890	256	269	healthy cells	T025	C0007634
28359890	271	275	Drug	T121	C1254351
28359890	283	305	magnetic nanoparticles	T073	C1450054
28359890	315	323	external	T082	C0205101
28359890	324	338	magnetic field	T070	C0563533
28359890	357	367	accumulate	UnknownType	C0678759
28359890	372	376	drug	T121	C1254351
28359890	384	395	target site	T029	C2348654
28359890	408	414	reduce	T080	C0392756
28359890	445	470	therapeutic concentration	UnknownType	C0683164
28359890	507	519	side effects	T046	C0879626
28359890	523	536	healthy cells	T025	C0007634
28359890	563	574	artemisinin	T109,T121	C0052430
28359890	575	597	magnetic nanoparticles	T073	C1450054
28359890	633	641	chitosan	T109,T121	C0162969
28359890	645	666	ionic-gelation method	T059	C0022885
28359890	682	704	magnetic nanoparticles	T073	C1450054
28359890	708	719	artemisinin	T109,T121	C0052430
28359890	725	731	smooth	T080	C0205357
28359890	736	745	spherical	T082	C0332501
28359890	766	770	size	T082	C0456389
28359890	806	826	polydispersity index	T077	C1882415
28359890	828	831	PDI	T077	C1882415
28359890	837	851	zeta potential	T067	C0597697
28359890	870	883	nanoparticles	T073	C1450054
28359890	978	982	drug	T121	C1254351
28359890	983	996	encapsulation	T067	C2348438
28359890	997	1007	efficiency	T081	C0013682
28359890	1023	1027	drug	T121	C1254351
28359890	1028	1044	loading capacity	T081	C1516240
28359890	1067	1078	artemisinin	T109,T121	C0052430
28359890	1083	1091	released	T169	C0391871
28359890	1101	1112	artemisinin	T109,T121	C0052430
28359890	1113	1135	magnetic nanoparticles	T073	C1450054
28359890	1145	1151	period	T079	C1948053
28359890	1163	1174	application	T169	C4048755
28359890	1178	1193	physiologically	T169	C0205463
28359890	1194	1204	acceptable	T080	C1879533
28359890	1205	1213	external	T082	C0205101
28359890	1214	1228	magnetic field	T070	C0563533
28359890	1230	1234	FITC	T109,T130	C0085216
28359890	1246	1257	artemisinin	T109,T121	C0052430
28359890	1258	1280	magnetic nanoparticles	T073	C1450054
28359890	1300	1312	accumulation	UnknownType	C0678759
28359890	1316	1329	nanoparticles	T073	C1450054
28359890	1337	1362	4T1 breast tumour tissues	T024	C0475358
28359890	1341	1347	breast	T023	C0006141
28359890	1366	1377	BALB/c mice	T015	C0025919
28359890	1378	1383	model	T050	C0012644